{
    "nctId": "NCT03270072",
    "briefTitle": "The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients",
    "officialTitle": "The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer Stage II, Breast Cancer Stage III",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Change in Global Longitudinal Strain (GLS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Eligible for and scheduled to receive radiation therapy on Radiation Therapy Oncology Group (RTOG) Trial 3510 (Pragmatic Phase III Randomized Trial of Proton vs Photon Therapy for Patients with Non-Metastatic Breast Cancer Receiving Comprehensive Nodal Radiation: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial). (NCT02603341)\n* Ability to understand and the willingness to sign a study-specific written informed consent document\n\nExclusion Criteria:\n\n* There are no exclusion criteria.",
    "sex": "ALL",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}